• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXSL2500113 VAY736注射液 ianalumab Injection Biological Products(1) Import Drug Application 2025-06-28 China Novartis Institutes For Biomedical Research Co Ltd;Novartis Pharma Schweiz AG view
JXSB2500038 VAY736注射液 ianalumab Injection Biological Products(1) Supplementary Application 2025-05-14 Novartis Pharma Stein AG;Novartis Pharma Schweiz AG view
JXSL2500057 VAY736注射液 ianalumab Injection Biological Products(1) Import Drug Application 2025-04-09 China Novartis Institutes For Biomedical Research Co Ltd;Novartis Pharma Schweiz AG view
JXSL2400223 VAY736注射液 ianalumab Injection Biological Products(1) Import Drug Application 2024-11-19 China Novartis Institutes For Biomedical Research Co Ltd;Novartis Pharma Schweiz AG view
JXSB2400145 VAY736注射液 ianalumab Injection Biological Products(1) Supplementary Application 2024-11-15 Novartis Pharma Stein AG;Novartis Pharma Schweiz AG view
JXSL2400105 VAY736注射液 ianalumab Injection Biological Products(1) Import Drug Application 2024-05-31 China Novartis Institutes For Biomedical Research Co Ltd;Novartis Pharma Schweiz AG view
JXSL2400070 VAY736注射液 ianalumab Injection Biological Products(1) Import Drug Application 2024-04-10 China Novartis Institutes For Biomedical Research Co Ltd;Novartis Pharma Schweiz AG view
JXSB2400035 VAY736注射液 ianalumab Injection Biological Products(1) Supplementary Application 2024-04-03 Lonza Group AG;Novartis Pharma Stein AG;Novartis Pharma Schweiz AG view
JXSB2300162 VAY736注射液 ianalumab Injection Biological Products(1) Supplementary Application 2023-12-14 Lonza Group AG;Novartis Pharma Schweiz AG view
JXSL2300176 VAY736注射液 ianalumab Injection Biological Products(1) Import Drug Application 2023-10-11 China Novartis Institutes For Biomedical Research Co Ltd;Novartis Pharma Schweiz AG view
JXSB2300098 VAY736注射液 ianalumab Injection Biological Products(1) Supplementary Application 2023-08-11 Novartis Pharma Stein AG;Novartis Pharma Schweiz AG view
JXSL2300132 VAY736注射液 ianalumab Injection Biological Products(1) Import Drug Application 2023-07-22 China Novartis Institutes For Biomedical Research Co Ltd;Novartis Pharma Schweiz AG view
JXSL2300091 VAY736注射液 ianalumab Injection Biological Products(1) Import Drug Application 2023-05-07 China Novartis Institutes For Biomedical Research Co Ltd;Novartis Pharma Schweiz AG view
JXSB2300050 VAY736注射液 ianalumab Injection Biological Products(1) Supplementary Application 2023-05-05 Lonza Group AG;Novartis Pharma Schweiz AG view
JXSL2300005 VAY736注射液 ianalumab Injection Biological Products(1) Import Drug Application 2023-01-05 China Novartis Institutes For Biomedical Research Co Ltd;Novartis Pharma Schweiz AG view
JXSL2200192 VAY736注射液 ianalumab Injection Biological Products(1) Import Drug Application 2022-11-05 China Novartis Institutes For Biomedical Research Co Ltd;Novartis Pharma Schweiz AG view
JXSL2200189 VAY736注射液 ianalumab Injection Biological Products(1) Import Drug Application 2022-10-29 China Novartis Institutes For Biomedical Research Co Ltd;Novartis Pharma Schweiz AG view
JXSL2200175 VAY736注射液 ianalumab Injection Biological Products(1) Import Drug Application 2022-09-30 China Novartis Institutes For Biomedical Research Co Ltd;Novartis Pharma Schweiz AG view
JXSL2200164 VAY736注射液 ianalumab Injection Biological Products(1) Import Drug Application 2022-09-14 China Novartis Institutes For Biomedical Research Co Ltd;Novartis Pharma Schweiz AG view
JXSB2200096 VAY736注射液 ianalumab Injection Biological Products(1) Supplementary Application 2022-07-20 Lonza Group AG;Novartis Pharma Schweiz AG view